A detailed history of Pro Share Advisors LLC transactions in Omeros Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,569 shares of OMER stock, worth $108,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,569
Holding current value
$108,966
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.54 - $5.47 $37,414 - $57,812
10,569 New
10,569 $41,000
Q1 2024

May 08, 2024

BUY
$2.88 - $4.89 $2,534 - $4,303
880 Added 8.75%
10,938 $37,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $2,116 - $7,114
-1,960 Reduced 16.31%
10,058 $32,000
Q3 2023

Nov 13, 2023

BUY
$2.81 - $5.69 $98 - $199
35 Added 0.29%
12,018 $35,000
Q2 2023

Aug 10, 2023

BUY
$4.45 - $7.57 $53,324 - $90,711
11,983 New
11,983 $65,000
Q2 2022

Aug 01, 2022

SELL
$1.92 - $6.28 $34,135 - $111,652
-17,779 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$5.07 - $7.2 $21,319 - $30,276
-4,205 Reduced 19.13%
17,779 $106,000
Q4 2021

Feb 08, 2022

BUY
$5.67 - $8.54 $5,142 - $7,745
907 Added 4.3%
21,984 $141,000
Q3 2021

Nov 12, 2021

SELL
$13.4 - $16.3 $77,264 - $93,985
-5,766 Reduced 21.48%
21,077 $291,000
Q2 2021

Aug 13, 2021

BUY
$14.81 - $19.13 $37,291 - $48,169
2,518 Added 10.35%
26,843 $398,000
Q1 2021

May 14, 2021

BUY
$14.52 - $23.53 $24,959 - $40,448
1,719 Added 7.6%
24,325 $433,000
Q4 2020

Feb 09, 2021

BUY
$10.14 - $15.19 $53,691 - $80,431
5,295 Added 30.59%
22,606 $323,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $21.32 $14,087 - $31,383
1,472 Added 9.29%
17,311 $175,000
Q2 2020

Aug 03, 2020

BUY
$12.21 - $16.99 $193,394 - $269,104
15,839 New
15,839 $233,000
Q1 2020

May 15, 2020

SELL
$9.03 - $19.72 $154,927 - $338,336
-17,157 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$13.01 - $17.15 $19,319 - $25,467
-1,485 Reduced 7.97%
17,157 $242,000
Q3 2019

Nov 12, 2019

SELL
$14.55 - $20.56 $8,759 - $12,377
-602 Reduced 3.13%
18,642 $304,000
Q2 2019

Aug 13, 2019

SELL
$15.0 - $19.62 $36,930 - $48,304
-2,462 Reduced 11.34%
19,244 $302,000
Q1 2019

May 15, 2019

BUY
$11.65 - $17.72 $3,250 - $4,943
279 Added 1.3%
21,706 $377,000
Q4 2018

Feb 14, 2019

SELL
$10.72 - $16.73 $42,665 - $66,585
-3,980 Reduced 15.66%
21,427 $239,000
Q3 2018

Nov 14, 2018

SELL
$17.73 - $26.69 $16,400 - $24,688
-925 Reduced 3.51%
25,407 $620,000
Q2 2018

Aug 13, 2018

SELL
$10.79 - $24.44 $18,094 - $40,985
-1,677 Reduced 5.99%
26,332 $478,000
Q1 2018

May 14, 2018

SELL
$9.0 - $20.16 $41,463 - $92,877
-4,607 Reduced 14.12%
28,009 $313,000
Q4 2017

Feb 14, 2018

BUY
$13.26 - $22.86 $34,635 - $59,710
2,612 Added 8.71%
32,616 $634,000
Q3 2017

Nov 13, 2017

BUY
$19.76 - $24.9 $74,475 - $93,848
3,769 Added 14.37%
30,004 $649,000
Q2 2017

Aug 11, 2017

BUY
N/A
26,235
26,235 $522,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.